AAAAAA
Results:
1-7
|
Results: 7
Authors:
Agrawal, NGB
Porras, AG
Matthews, CZ
Woolf, EJ
Miller, JL
Mukhopadhyay, S
Neu, DC
Gottesdiener, KM
Citation: Ngb. Agrawal et al., Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers, J CLIN PHAR, 41(10), 2001, pp. 1106-1110
Authors:
Schwartz, JI
Agrawal, NGB
Wong, PH
Bachmann, KA
Porras, AG
Miller, JL
Ebel, DL
Sack, MR
Holmes, GB
Redfern, JS
Gertz, BJ
Citation: Ji. Schwartz et al., Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients, J CLIN PHAR, 41(10), 2001, pp. 1120-1130
Authors:
Schwartz, JI
De Smet, M
Larson, PJ
Verbesselt, R
Ebel, DL
Lins, R
Lens, S
Porras, AG
Gertz, BJ
Citation: Ji. Schwartz et al., Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers, J CLIN PHAR, 41(1), 2001, pp. 107-112
Authors:
Schwartz, JI
Bugianesi, KJ
Ebel, DL
De Smet, M
Haesen, R
Larson, PJ
Ko, A
Verbesselt, R
Hunt, TL
Lins, R
Lens, S
Porras, AG
Dieck, J
Keymeulen, B
Gertz, BJ
Citation: Ji. Schwartz et al., The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin, CLIN PHARM, 68(6), 2000, pp. 626-636
Authors:
Porras, AG
Holland, SD
Gertz, BJ
Citation: Ag. Porras et al., Pharmacokinetics of alendronate, CLIN PHARMA, 36(5), 1999, pp. 315-328
Authors:
Cocquyt, V
Kline, WF
Gertz, BJ
Van Belle, SJP
Holland, SD
DeSmet, M
Quan, H
Vyas, KP
Zhang, KYE
De Greve, J
Porras, AG
Citation: V. Cocquyt et al., Pharmacokinetics of intravenous alendronate, J CLIN PHAR, 39(4), 1999, pp. 385-393
Authors:
Rogers, JD
Zhao, J
Liu, LD
Amin, RD
Gagliano, KD
Porras, AG
Blum, RA
Wilson, MF
Stepanavage, M
Vega, JM
Citation: Jd. Rogers et al., Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, CLIN PHARM, 66(4), 1999, pp. 358-366
Risultati:
1-7
|